{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:46:10Z","timestamp":1794901570236,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T00:00:00Z","timestamp":1699747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T00:00:00Z","timestamp":1699747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2020R1I1A1A01060447"],"award-info":[{"award-number":["NRF-2020R1I1A1A01060447"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2021R1I1A1A0104944111"],"award-info":[{"award-number":["NRF-2021R1I1A1A0104944111"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular disease (CVD) is a major complication in type 1 diabetes mellitus (T1D) patients. Previous studies have suggested that statins may be helpful for prevention of CVD in T1D, but there are limited data on the role of statins in T1D. We investigated the relationship between statin treatment and cardiovascular risk in T1D patients using a population-based cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study using the Korean nationwide health insurance database from January 2007 to December 2017. This study included 11,009 T1D patients aged\u2009\u2265\u200920\u00a0years without a prior history of CVD. The primary outcome was a composite development of stroke or myocardial infarction. Statin use during follow-up was treated as a time-varying variable. We performed a multivariable time-dependent Cox regression analysis adjusting for sex, age, type of insurance, hypertension, renal disease, and use of antiplatelets and renin\u2013angiotensin\u2013aldosterone system inhibitors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During the mean follow-up of 9.9\u2009\u00b1\u20093.7\u00a0years of follow-up, 931 T1D patients (8.5%) suffered primary outcome. Statin treatment was associated with a reduced risk of the primary outcome (adjusted hazard ratio, 0.76; 95% confidence interval 0.66\u20130.88; p\u2009&lt;\u20090.001). Statin use led to decreased risks of ischemic stroke and myocardial infarction, but was not related to hemorrhagic stroke. We also found that the risk of cardiovascular events decreased as the cumulative exposure duration of statins increased.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Statin use was associated with a lower risk of cardiovascular events in T1D patients. Further prospective studies are needed to confirm the potential role of statins in prevention of CVD in patients with T1D.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-023-04691-6","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T23:12:02Z","timestamp":1699744322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Impact of statin treatment on cardiovascular risk in patients with type 1 diabetes: a population-based cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Joonsang","family":"Yoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyoul","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Ok","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0156-9736","authenticated-orcid":false,"given":"Jinkwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,12]]},"reference":[{"key":"4691_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"MA Atkinson","year":"2014","unstructured":"Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014;383:69\u201382.","journal-title":"Lancet"},{"key":"4691_CR2","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.2337\/dc14-1720","volume":"37","author":"SD de Ferranti","year":"2014","unstructured":"de Ferranti SD, de Boer IH, Fonseca V, Fox CS, Golden SH, Lavie CJ, Magge SN, Marx N, McGuire DK, Orchard TJ, et al. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American heart association and American diabetes association. Diabetes Care. 2014;37:2843\u201363.","journal-title":"Diabetes Care"},{"key":"4691_CR3","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, Benetos A, Biffi A, Boavida JM, Capodanno D, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227\u2013337.","journal-title":"Eur Heart J"},{"key":"4691_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.5853\/jos.2021.01249","volume":"23","author":"JS Kim","year":"2021","unstructured":"Kim JS. Role of blood lipid levels and lipid-lowering therapy in stroke patients with different levels of cerebral artery diseases: reconsidering recent stroke guidelines. J Stroke. 2021;23:149\u201361.","journal-title":"J Stroke"},{"key":"4691_CR5","doi-asserted-by":"publisher","first-page":"k3359","DOI":"10.1136\/bmj.k3359","volume":"362","author":"R Ramos","year":"2018","unstructured":"Ramos R, Comas-Cuf\u00ed M, Mart\u00ed-Lluch R, Ball\u00f3 E, Ponjoan A, Alves-Cabratosa L, Blanch J, Marrugat J, Elosua R, Grau M, et al. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study. BMJ. 2018;362:k3359.","journal-title":"BMJ"},{"key":"4691_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/pdi.1990","volume":"33","author":"M Fisher","year":"2016","unstructured":"Fisher M. Statins for people with type 1 diabetes: when should treatment start? Pract Diab. 2016;33:10\u20131.","journal-title":"Pract Diab"},{"key":"4691_CR7","first-page":"S144","volume":"45","author":"ADAPP Committee","year":"2021","unstructured":"Committee ADAPP. 10 Cardiovascular disease and risk management: standards of medical care in diabetes\u20142022. Diabetes Care. 2021;45:S144\u201374.","journal-title":"Diabetes Care"},{"key":"4691_CR8","doi-asserted-by":"publisher","first-page":"g4356","DOI":"10.1136\/bmj.g4356","volume":"349","author":"S Rabar","year":"2014","unstructured":"Rabar S, Harker M, O\u2019Flynn N, Wierzbicki AS. Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. BMJ: Br Med J. 2014;349:g4356.","journal-title":"BMJ: Br Med J"},{"key":"4691_CR9","doi-asserted-by":"publisher","first-page":"996","DOI":"10.2337\/dc15-2450","volume":"39","author":"C Hero","year":"2016","unstructured":"Hero C, Rawshani A, Svensson AM, Franz\u00e9n S, Eliasson B, Eeg-Olofsson K, Gudbj\u00f6rnsdottir S. Association between use of lipid-lowering therapy and cardiovascular diseases and death in individuals with type 1 diabetes. Diabetes Care. 2016;39:996\u20131003.","journal-title":"Diabetes Care"},{"key":"4691_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.4093\/dmj.2020.0207","volume":"44","author":"HK Kim","year":"2020","unstructured":"Kim HK, Song SO, Noh J, Jeong IK, Lee BW. Data configuration and publication trends for the Korean national health insurance and health insurance review & assessment database. Diabetes Metab J. 2020;44:671\u20138.","journal-title":"Diabetes Metab J"},{"key":"4691_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4093\/dmj.2016.40.1.35","volume":"40","author":"SO Song","year":"2016","unstructured":"Song SO, Song YD, Nam JY, Park KH, Yoon JH, Son KM, Ko Y, Lim DH. Epidemiology of type 1 diabetes mellitus in Korea through an investigation of the national registration project of type 1 diabetes for the reimbursement of glucometer strips with additional analyses using claims data. Diabetes Metab J. 2016;40:35\u201345.","journal-title":"Diabetes Metab J"},{"key":"4691_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/cid\/ciaa1384","volume":"73","author":"J Kim","year":"2021","unstructured":"Kim J, Jeon J, Lee HS, Lee KY. Association between the risk for cardiovascular events and antiviral treatment for herpes zoster. Clin Infect Dis. 2021;73:758\u201364.","journal-title":"Clin Infect Dis"},{"key":"4691_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3988\/jcn.2016.12.1.42","volume":"12","author":"TH Park","year":"2016","unstructured":"Park TH, Choi JC. Validation of stroke and thrombolytic therapy in Korean national health insurance claim data. J Clin Neurol. 2016;12:42\u20138.","journal-title":"J Clin Neurol"},{"key":"4691_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s42444-019-0005-0","volume":"20","author":"J Park","year":"2019","unstructured":"Park J, Kwon S, Choi E-K, Choi Y-j, Lee E, Choe W, Lee S-R, Cha M-J, Lim W-H, Oh S. Validation of diagnostic codes of major clinical outcomes in a national health insurance database. Int J Arrhythm. 2019;20:5.","journal-title":"Int J Arrhythm"},{"key":"4691_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1161\/HYPERTENSIONAHA.118.11139","volume":"72","author":"J Kim","year":"2018","unstructured":"Kim J, Bushnell CD, Lee HS, Han SW. Effect of adherence to antihypertensive medication on the long-term outcome after hemorrhagic stroke in Korea. Hypertension. 2018;72:391\u20138.","journal-title":"Hypertension"},{"key":"4691_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.21032\/jhis.2020.45.4.356","volume":"45","author":"HJ Seo","year":"2020","unstructured":"Seo HJ. Effects for comorbidities of chronic kidney disease on the progression to end-stage renal disease. J Health Info Stat. 2020;45:356\u201364.","journal-title":"J Health Info Stat"},{"key":"4691_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2288-8-48","volume":"8","author":"CJ Biesheuvel","year":"2008","unstructured":"Biesheuvel CJ, Vergouwe Y, Oudega R, Hoes AW, Grobbee DE, Moons KGM. Advantages of the nested case-control design in diagnostic research. BMC Med Res Methodol. 2008;8:48.","journal-title":"BMC Med Res Methodol"},{"key":"4691_CR18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s13300-019-0612-8","volume":"10","author":"J Schofield","year":"2019","unstructured":"Schofield J, Ho J, Soran H. Cardiovascular risk in type 1 diabetes mellitus. Diabetes Ther. 2019;10:773\u201389.","journal-title":"Diabetes Ther"},{"key":"4691_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12933-019-0953-7","volume":"18","author":"YB Lee","year":"2019","unstructured":"Lee YB, Han K, Kim B, Lee SE, Jun JE, Ahn J, Kim G, Jin SM, Kim JH. Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study. Cardiovasc Diabetol. 2019;18:157.","journal-title":"Cardiovasc Diabetol"},{"key":"4691_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijcard.2018.03.099","volume":"262","author":"SC Larsson","year":"2018","unstructured":"Larsson SC, Wallin A, H\u00e5kansson N, Stackelberg O, B\u00e4ck M, Wolk A. Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases. Int J Cardiol. 2018;262:66\u201370.","journal-title":"Int J Cardiol"},{"key":"4691_CR21","doi-asserted-by":"publisher","first-page":"798","DOI":"10.2337\/diacare.29.04.06.dc05-1433","volume":"29","author":"SS Soedamah-Muthu","year":"2006","unstructured":"Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care. 2006;29:798\u2013804.","journal-title":"Diabetes Care"},{"key":"4691_CR22","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.2337\/dc22-0042","volume":"45","author":"AM Kerola","year":"2022","unstructured":"Kerola AM, Juonala M, Palom\u00e4ki A, Semb AG, Rautava P, Kyt\u00f6 V. Case fatality of patients with type 1 diabetes after myocardial infarction. Diabetes Care. 2022;45:1657\u201365.","journal-title":"Diabetes Care"},{"key":"4691_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1475-2840-12-156","volume":"12","author":"O Schnell","year":"2013","unstructured":"Schnell O, Cappuccio F, Genovese S, Standl E, Valensi P, Ceriello A. Type 1 diabetes and cardiovascular disease. Cardiovasc Diabetol. 2013;12:156.","journal-title":"Cardiovasc Diabetol"},{"key":"4691_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-005-0120-4","volume":"49","author":"SS Soedamah-Muthu","year":"2006","unstructured":"Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992\u20131999. Diabetologia. 2006;49:660\u20136.","journal-title":"Diabetologia"},{"key":"4691_CR25","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.2337\/db10-0862","volume":"59","author":"AM Secrest","year":"2010","unstructured":"Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard TJ. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes. 2010;59:3216\u201322.","journal-title":"Diabetes"},{"key":"4691_CR26","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","volume":"392","author":"A Rawshani","year":"2018","unstructured":"Rawshani A, Sattar N, Franz\u00e9n S, Rawshani A, Hattersley AT, Svensson AM, Eliasson B, Gudbj\u00f6rnsdottir S. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet. 2018;392:477\u201386.","journal-title":"Lancet"},{"key":"4691_CR27","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1161\/CIRCULATIONAHA.118.038137","volume":"139","author":"JR Petrie","year":"2019","unstructured":"Petrie JR, Sattar N. Excess cardiovascular risk in type 1 diabetes mellitus. Circulation. 2019;139:744\u20137.","journal-title":"Circulation"},{"key":"4691_CR28","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.2337\/diacare.26.10.2923","volume":"26","author":"JK Snell-Bergeon","year":"2003","unstructured":"Snell-Bergeon JK, Hokanson JE, Jensen L, MacKenzie T, Kinney G, Dabelea D, Eckel RH, Ehrlich J, Garg S, Rewers M. Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control. Diabetes Care. 2003;26:2923\u20138.","journal-title":"Diabetes Care"},{"key":"4691_CR29","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.2337\/dc19-1126","volume":"42","author":"A Keshawarz","year":"2019","unstructured":"Keshawarz A, Pyle L, Alman A, Sassano C, Westfeldt E, Sippl R, Snell-Bergeon J. Type 1 diabetes accelerates progression of coronary artery calcium over the menopausal transition: the CACTI study. Diabetes Care. 2019;42:2315\u201321.","journal-title":"Diabetes Care"},{"key":"4691_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4239\/wjd.v12.i1.56","volume":"12","author":"S Krepel Volsky","year":"2021","unstructured":"Krepel Volsky S, Shalitin S, Fridman E, Yackobovitch-Gavan M, Lazar L, Bello R, Oron T, Tenenbaum A, de Vries L, Lebenthal Y. Dyslipidemia and cardiovascular disease risk factors in patients with type 1 diabetes: a single-center experience. World J Diabetes. 2021;12:56\u201368.","journal-title":"World J Diabetes"},{"key":"4691_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4093\/dmj.2018.0048","volume":"43","author":"YB Lee","year":"2019","unstructured":"Lee YB, Han K, Kim B, Jin SM, Lee SE, Jun JE, Ahn J, Kim G, Kim JH. High proportion of adult cases and prevalence of metabolic syndrome in type 1 diabetes mellitus population in Korea: a nationwide study. Diabetes Metab J. 2019;43:76\u201389.","journal-title":"Diabetes Metab J"},{"key":"4691_CR32","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1161\/CIRCULATIONAHA.118.037454","volume":"139","author":"A Rawshani","year":"2019","unstructured":"Rawshani A, Rawshani A, Sattar N, Franz\u00e9n S, McGuire DK, Eliasson B, Svensson AM, Zethelius B, Miftaraj M, Rosengren A, Gudbj\u00f6rnsdottir S. Relative prognostic importance and optimal levels of risk factors for mortality and cardiovascular outcomes in type 1 diabetes mellitus. Circulation. 2019;139:1900\u201312.","journal-title":"Circulation"},{"key":"4691_CR33","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.jacc.2017.07.001","volume":"70","author":"JD Newman","year":"2017","unstructured":"Newman JD, Schwartzbard AZ, Weintraub HS, Goldberg IJ, Berger JS. Primary prevention of cardiovascular disease in diabetes mellitus. J Am Coll Cardiol. 2017;70:883\u201393.","journal-title":"J Am Coll Cardiol"},{"key":"4691_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00392-016-1069-7","volume":"106","author":"H Soran","year":"2017","unstructured":"Soran H, Dent R, Durrington P. Evidence-based goals in LDL-C reduction. Clin Res Cardiol. 2017;106:237\u201348.","journal-title":"Clin Res Cardiol"},{"key":"4691_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12933-019-0861-x","volume":"18","author":"M Svanteson","year":"2019","unstructured":"Svanteson M, Holte KB, Haig Y, Kl\u00f8w NE, Berg TJ. Coronary plaque characteristics and epicardial fat tissue in long term survivors of type 1 diabetes identified by coronary computed tomography angiography. Cardiovasc Diabetol. 2019;18:58.","journal-title":"Cardiovasc Diabetol"},{"key":"4691_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","volume":"371","author":"PM Kearney","year":"2008","unstructured":"Kearney PM, Blackwell L, Collins R, Keech A, Simes J, Peto R, Armitage J, Baigent C. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 2008;371:117\u201325.","journal-title":"Lancet"},{"key":"4691_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/XCE.0000000000000169","volume":"8","author":"A Jenkins","year":"2019","unstructured":"Jenkins A, Januszewski A, O\u2019Neal D. The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it. Cardiovasc Endocrinol Metab. 2019;8:14\u201327.","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"4691_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/01.CIR.0000131517.20177.5a","volume":"109","author":"J Davignon","year":"2004","unstructured":"Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004;109:39\u201343.","journal-title":"Circulation"},{"key":"4691_CR39","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1464-5491.2005.01562.x","volume":"22","author":"G Targher","year":"2005","unstructured":"Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy. Diabet Med. 2005;22:999\u20131004.","journal-title":"Diabet Med"},{"key":"4691_CR40","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/dmrr.1195","volume":"27","author":"C Giannini","year":"2011","unstructured":"Giannini C, Mohn A, Chiarelli F, Kelnar CJ. Macrovascular angiopathy in children and adolescents with type 1 diabetes. Diabetes Metab Res Rev. 2011;27:436\u201360.","journal-title":"Diabetes Metab Res Rev"},{"key":"4691_CR41","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.2337\/dc07-1960","volume":"31","author":"AS Astrup","year":"2008","unstructured":"Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate. Diabetes Care. 2008;31:1170\u20136.","journal-title":"Diabetes Care"},{"key":"4691_CR42","first-page":"567","volume":"3","author":"P Gelosa","year":"2007","unstructured":"Gelosa P, Cimino M, Pignieri A, Tremoli E, Guerrini U, Sironi L. The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation. Vasc Health Risk Manag. 2007;3:567\u201377.","journal-title":"Vasc Health Risk Manag"},{"key":"4691_CR43","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1001\/jamainternmed.2021.5714","volume":"181","author":"IA Mansi","year":"2021","unstructured":"Mansi IA, Chansard M, Lingvay I, Zhang S, Halm EA, Alvarez CA. Association of statin therapy initiation with diabetes progression: a retrospective matched-cohort study. JAMA Intern Med. 2021;181:1562\u201374.","journal-title":"JAMA Intern Med"},{"key":"4691_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.diabres.2015.10.022","volume":"111","author":"MT Jensen","year":"2016","unstructured":"Jensen MT, Andersen HU, Rossing P, Jensen JS. Statins are independently associated with increased HbA1c in type 1 diabetes\u2013the thousand & 1 study. Diabetes Res Clin Pract. 2016;111:51\u20137.","journal-title":"Diabetes Res Clin Pract"},{"key":"4691_CR45","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jacl.2016.04.012","volume":"10","author":"L Duvnjak","year":"2016","unstructured":"Duvnjak L, Blaslov K. Statin treatment is associated with insulin sensitivity decrease in type 1 diabetes mellitus: a prospective, observational 56-month follow-up study. J Clin Lipidol. 2016;10:1004\u201310.","journal-title":"J Clin Lipidol"},{"key":"4691_CR46","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMoa061894","volume":"355","author":"P Amarenco","year":"2006","unstructured":"Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549\u201359.","journal-title":"N Engl J Med"},{"key":"4691_CR47","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.2337\/dci21-0043","volume":"44","author":"RIG Holt","year":"2021","unstructured":"Holt RIG, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, Klupa T, Ludwig B, N\u00f8rgaard K, Pettus J, Renard E, et al. The management of type 1 diabetes in adults. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care. 2021;44:2589\u2013625.","journal-title":"Diabetes Care"},{"key":"4691_CR48","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12933-020-01137-x","volume":"19","author":"N Tecce","year":"2020","unstructured":"Tecce N, Masulli M, Lupoli R, Della Pepa G, Bozzetto L, Palmisano L, Rivellese AA, Riccardi G, Capaldo B. Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the steno type 1 risk engine. Cardiovasc Diabetol. 2020;19:166.","journal-title":"Cardiovasc Diabetol"},{"key":"4691_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/ehjqcco\/qcv002","volume":"1","author":"TK Law","year":"2015","unstructured":"Law TK, Yan AT, Gupta A, Kajil M, Tsigoulis M, Singh N, Verma S, Gupta M. Primary prevention of cardiovascular disease: global cardiovascular risk assessment and management in clinical practice. Eur Heart J Qual Care Clin Outcomes. 2015;1:31\u20136.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"4691_CR50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.diabet.2018.12.002","volume":"46","author":"NSR Lan","year":"2020","unstructured":"Lan NSR, Yeap BB, Bell DA, Watts GF, Fegan PG. Patients with type 1 diabetes in a tertiary setting do not attain recommended lipid targets. Diabetes Metab. 2020;46:339\u201341.","journal-title":"Diabetes Metab"},{"key":"4691_CR51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12933-015-0318-9","volume":"15","author":"JW Bai","year":"2016","unstructured":"Bai JW, Boulet G, Halpern EM, Lovblom LE, Eldelekli D, Keenan HA, Brent M, Paul N, Bril V, Cherney DZ, et al. Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort. Cardiovasc Diabetol. 2016;15:14.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04691-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04691-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04691-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T23:12:07Z","timestamp":1699744327000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04691-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,12]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4691"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04691-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2491965\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,12]]},"assertion":[{"value":"18 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Yongin Severance Hospital, Yonsei University College of Medicine (9-2021-0119). The requirement for informed consent in this study was waived because of its retrospective nature, and analyses were performed using fully anonymized data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J.Y. and J.K. report research grants from Chong Kun Dang pharmaceutical.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"806"}}